Infectious diseases are caused by microorganisms such as bacteria and viruses. These microorganisms are normally harmless; however, under specific conditions, they may cause a disease. Infectious diseases can be transmitted from one person to another or they can be transmitted through animal bites. Hence, infectious diseases are also known as transmissible diseases. Fever, diarrhea, fatigue, and coughing are some of the symptoms of infectious diseases. According to the Global Burden of Disease Study–2013, infectious diseases caused 9.2 million death across the globe in 2013.
Based on product, the global infectious disease diagnostics market can be segmented into assays and kits & reagents. The kits & reagents segment is likely to expand at a significant pace during the forecast period, as kits and reagents are fast-moving consumable things that are used in the diagnostic procedure to conduct the diagnostic test. Based on disease type, the market can be segmented into hepatitis, HIV, TB, influenza, and others. The hepatitis segment is likely to expand at a significant pace during the forecast period, as the prevalence of hepatitis is increasing across the globe at a higher pace compared to other disease types. Based on technology, the infectious disease diagnostics market can be segmented into immunodiagnostics, PCR, NGS, and others. The PRC (polymerase chain reaction) segment is likely to expand at a significant pace during the forecast period, as the polymerase chain reaction permits analysis of any short sequence of DNA even if the sample contains only minute quantities of nucleotides. In terms of end-user, the global infectious disease diagnostics market can be segmented into hospitals, diagnostic laboratories, and research institutes. The hospitals segment is likely to expand at a significant pace during the forecast period, as most patients prefer to visit hospitals so as to obtain the treatment and diagnosis at the same place. Moreover, compared to other end-users, a larger number of diagnostic tests are conducted in hospitals.
Increase in the prevalence of infectious diseases such as TB and influenza is one of the major factors fueling the global infectious disease diagnostics market. Moreover, rise in funding for research on the diagnosis of infectious diseases is projected to drive the market during the forecast period. However, undeveloped health care infrastructure in underdeveloped countries is likely to hamper the market in the next few years.
In terms of region, the global infectious disease diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global market during the forecast period, due to rise in the prevalence of infectious diseases and presence of a highly developed health care system in the region. Presence of leading national clinical laboratories such as Eurofins Scientific and easy accessibility of advanced instruments that can be used in diagnostic procedures are a few factors that are likely to drive the Europe market from 2018 to 2026. Increase in the prevalence of infectious diseases and rise in the adoption of advanced diagnostic tools in the health care system in the region are likely to fuel the market in Asia Pacific during the forecast period. Rise in the prevalence of diseases such as malaria, meningitis, and rubella in central Africa is likely to augment the infectious disease diagnostics market in Middle East & Africa during the forecast period.
Key players operating in the global infectious disease diagnostics market are Abbott, Becton, Dickinson and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., Alere, Inc., Ortho-Clinical Diagnostics, and F. Hoffmann-La Roche Ltd.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.